The logic isn't "more peptides = better." It's that these two peptides address different bottlenecks in the healing process
Disclosure of interest: nothing to discloser E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P2109 - ESOC25-1903 TRIIODOTHYRONINE TREATMENT REDUCES STROKE VOLUME AND IMPROVES NEUROLOGICAL FUNCTION IN A MOUSE MODEL OF ISCHEMIC STROKE Daniel Ullrich 1,2 , Heike Heuer 2,3 , Steffen Mayerl 2,3 , Dagmar Fhrer 2,3 , Christoph Kleinschnitz 1,2 , Friederike Langhauser 1,2 1 Department of Neurology, University Hospital Essen, Germany, Essen, Germany, 2 Center for Translational Neuro- and Behavioural Sciences (C-TNBS), University Hospital Essen, Germany, E, Germany, 3 Department of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University Duisburg-Essen, Germany, Essen, Germany Background and Aims: Thyroid hormones affect the central nervous system's response to various stimuli such as ischemic stroke
However, recent research has established a link between intestinal permeability and a host of autoimmune diseases including Chrons disease, Hashimotos Thyroiditis, lupus erythematosus, psoriasis, and rheumatoid arthritis
Two independent meta-analyses of whole exome sequencing also revealed that AKAP11 -coding or truncating variants enhanced the risk of SCZ across diverse human populations 2,3
